FMR LLC

Position in GTBP — GT Biopharma, Inc.

CIK 315066 BOSTON, MA

Position in GTBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$408

+$138 QoQ

Shares Held

+1900.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,906,213,149 across 370 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	5,231,452	$4,853,584,218
2	ALNY	Alnylam Pharmaceuticals, Inc.	15,023,962	$4,522,663,276
3	MRNA	Moderna, Inc.	51,859,891	$3,631,748,165
4	ROIV	Roivant Sciences Ltd.	81,020,390	$2,867,311,601
5	RVMD	Revolution Medicines, Inc.	12,200,422	$2,284,895,029
6	IONS	Ionis Pharmaceuticals Inc	24,631,956	$1,953,067,789
7	INSM	INSMED Inc	16,143,583	$1,721,228,815
8	KRYS	Krystal Biotech, Inc.	4,418,197	$1,642,111,277

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$408	1,000	+1539.3%	Shares	Defined	2026-05-15
2024-03-31	$270	61	-59.3%	Shares	Defined	2024-05-13
2023-09-30	$36	150	-99.3%	Shares	Defined	2023-11-13
2023-06-30	$7,184	23,030	-54.7%	Shares	Defined	2023-08-11
2023-03-31	$27,985	50,882	0.0%	Shares	Defined	2023-08-11
2022-12-31	$45,081	50,882	-1.7%	Shares	Defined	2023-02-13
2022-09-30	$91,062	51,740	-6.3%	Shares	Defined	2022-11-10
2022-06-30	$165,121	55,225	+7.6%	Shares	Defined	2022-08-12
2022-03-31	$147,872	51,345	+40329.1%	Shares	Defined	2022-05-13
2021-09-30	$855	127	+370.4%	Shares	Defined	2022-02-14
2021-06-30	$418	27	—	Shares	Defined	2021-08-13
No filing history on record for this holder in this stock.